<DOC>
	<DOCNO>NCT02649959</DOCNO>
	<brief_summary>This Phase III , open label extension study evaluate continue safety efficacy CM-AT pediatric patient autism level fecal chymotrypsin .</brief_summary>
	<brief_title>An Open Label Study CM-AT Treatment Children With Autism</brief_title>
	<detailed_description>Autism clearly significant cause disability pediatric population . Treatment base observation many child autism digest protein . CM-AT proprietary enzyme design granulate powder take three time daily .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Age 3 8 year , inclusive , time signing inform consent/assent Sponsor 00103 Study Completion Sponsor 's 00103 Study continue meet eligibility requirement Currently 00102 open label study continue meet eligibility requirement Subjects initially qualified 00103 screening , subsequently fail Baseline entrance criterion randomization ( @ Visit 1 ) Baseline assessment ABC eligibility requirement continue meet eligibility requirement Up 20 subject 917 year age directly enroll study , meet current Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) diagnostic criterion Autistic Disorder ( AD ) , screen SCQ confirm ADIR Patient weigh &lt; 13kg Allergy porcine product Previous sensitization allergy trypsin , pancreatin , pancrelipase History severe head trauma , define loss consciousness hospitalization , skull fracture stroke . Seizure within last year prior enrollment , need seizure medication either present past . Evidence history severe , moderate uncontrolled systemic disease Ongoing dietary restriction allergy reason except nut allergy . Lactose free allowable dairy free . Inability ingest study drug / noncompliance dose schedule . Inability follow prescribe dosing schedule . Use stimulant nonstimulant medication medication give attention deficit hyperactivity disorder ( ADHD ) must discontinue 5 day prior initial randomize study period . Subjects take selective serotonin reuptake inhibitor ( SSRI ) must stable dose minimum 30 day prior enter study . History premature birth &lt; 35 week gestation . Prior history stroke utero utero insult .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autism</keyword>
</DOC>